Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/21/20244:00PMGlobeNewswire Inc.HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by TakedaNASDAQ:HCMHUTCHMED China Limited
06/21/20244:00PMGlobeNewswire Inc.Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024TG:6IVInventiva
06/21/20244:00PMGlobeNewswire Inc.Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  EU:IVAInventiva
06/21/20244:00PMBusiness WireTakeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal CancerNYSE:TAKTakeda Pharmaceutical Company Ltd
06/21/20244:00PMGlobeNewswire Inc.Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  TG:6IVInventiva
06/21/20244:00PMBusiness WirePennsylvania American Water Applies for East Dunkard Water Authority Acquisition ApprovalNYSE:AWKAmerican Water Works
06/21/20244:00PMGlobeNewswire Inc.Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  EU:IVAInventiva
06/21/20244:00PMGlobeNewswire Inc.In order to complete Meraki refinancing Baltic Horizon Fund requests for a waiver and bondholders consent under the bond terms and conditions
06/21/20244:00PMGlobeNewswire Inc.Results of the votes of the Combined Shareholders’ General Meeting of June 20, 2024  LSE:0RNKInventiva Sa
06/21/20244:00PMGlobeNewswire Inc.CoinShares Announces FlowBank Holdings SA Investment ImpairmentTG:3TWCoinShares International Limited
06/21/20244:00PMGlobeNewswire Inc.Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024EU:IVAInventiva
06/21/20244:00PMGlobeNewswire Inc.HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda4502.T
06/21/20244:00PMGlobeNewswire Inc.Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunies le 20 juin 2024LSE:0RNKInventiva Sa
06/21/20244:00PMGlobeNewswire Inc.HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by TakedaNYSE:TAKTakeda Pharmaceutical Company Ltd
06/21/20244:00PMGlobeNewswire Inc.In order to complete Meraki refinancing Baltic Horizon Fund requests for a waiver and bondholders consent under the bond terms and conditions
06/21/20243:57PMPR Newswire (Canada)Iconic Niagara Winery Château des Charmes Has Been Sold
06/21/20243:57PMBusiness WireQpiAI conclut un financement de présérie A de 6,5 millions de dollars, mené par Yournest et SIDBI Venture Capital, permettant la modélisation et le calcul de l’intelligence à l’aide d’ordinateurs quantiques
06/21/20243:56PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
06/21/20243:54PMBusiness WireFrank Zappa & the Mothers of Invention’s Wild Three-hour Concert Recorded Live at the Whisky a Go Go in 1968 out Now as Whisky a Go Go, 1968
06/21/20243:52PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:BMOLFBank of Montreal (PK)
06/21/20243:51PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:BMOLFBank of Montreal (PK)
06/21/20243:50PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SQLSeqLL Inc
06/21/20243:50PMBusiness WireMica Nguyen Worthy of Cranfill Sumner LLP Submits First-of-its-Kind Claim to NASA Seeking Recovery From Damages Sustained From Space Debris
06/21/20243:49PMPR Newswire (US)Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolutionNYSE:LLYEli Lilly and Co
06/21/20243:47PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:RYBPFRoyal Bank (PK)
06/21/20243:46PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesUSOTC:BMOLFBank of Montreal (PK)
06/21/20243:45PMBusiness WireVertex Announces Positive Results From Ongoing Phase 1/2 Study of VX-880 for the Treatment of Type 1 Diabetes Presented at the American Diabetes Association 84th Scientific SessionsNASDAQ:VRTXVertex Pharmaceuticals Inc
06/21/20243:45PMPR Newswire (US)Use of Tirzepatide Shown to Improve Sleep Apnea and Cardiovascular Outcomes
06/21/20243:45PMPR Newswire (US)Common Cholesterol-Lowering Drug Found to Slow Vision Loss in Diabetes Patients
06/21/20243:45PMPR Newswire (US)Expanded FORWARD Trial Demonstrates Continued Potential for Stem Cell-Derived Islet Cell Therapy to Eliminate Need for Insulin for People with T1D